市場調查報告書
商品編碼
1471241
放射治療設備市場:按類型、應用和最終用戶分類 - 全球預測 2024-2030Radiation Therapy Equipment Market by Type (External Beam Radiotherapy, Internal Beam Radiotherapy), Application (Cancer, Non-cancer), End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年放射治療設備市場規模為77.6億美元,預計2024年將達82.8億美元,2030年將達到125.5億美元,複合年成長率為7.11%。
放射治療設備是一種利用放射線治療癌症和其他疾病的醫療設備。放射治療可以精確地瞄準腫瘤,同時最大限度地減少對附近健康組織的損害。放射治療機通常高功率,可以提供不同的劑量水平,使醫生能夠為每位患者量身定做治療計劃。癌症的普及和外科手術的日益普及是推動對先進放射治療設備的需求的主要因素。各國政府採取了多項舉措來擴大癌症治療的覆蓋範圍,保險報銷的改善使更多的患者能夠接受治療。然而,政府對設備核准的嚴格規定阻礙了許多經濟體的設備普及。市場相關人員一直致力於透過數位化和自動化來提高放射治療設備的操作能力,同時保持最大程度的品管,以確保產品核可。此外,公共和私人對癌症治療研究和開發的投資正在迅速增加,預計將加速新治療設備的開發。
主要市場統計 | |
---|---|
基準年[2023] | 77.6億美元 |
預測年份 [2024] | 82.8億美元 |
預測年份 [2030] | 125.5億美元 |
複合年成長率(%) | 7.11% |
粒子束治療系統的進步使得更精確的放射治療成為可能。
外部放射治療 (EBRT) 是一種非侵入性方法,可從體外向腫瘤提供高劑量的放射線。傳統的鈷60遠端醫療裝置是最早用於癌症治療的體外放射治療裝置之一。該設備使用放射性鈷 60 源發射的伽馬射線來破壞癌組織。線性加速器,稱為直線加速器,是外部放射治療的現代形式。線性加速器向患者的腫瘤區域發送高能量 X 光和電子束。這些設備用途極為廣泛,並且可以實現相當高的精度和控制,因為劑量可以根據腫瘤的3D形狀進行調整。粒子治療系統是外束放射治療的尖端和先進子集,它使用質子和重離子等粒子代替 X光來治療癌症。這些系統,包括質子療法和碳離子療法,利用了稱為布拉格峰的獨特物理優勢,在粒子在組織中靜止之前發生最大能量釋放,從而可以精確地傳遞輻射。內束放射治療將放射源放置在腫瘤本身內部或附近。當腫瘤部位需要直接接受高劑量輻射時,這種類型的治療是必要的,並且通常用於治療前列腺癌、子宮頸癌和乳腺癌等疾病。後荷機在近距離放射治療(一種體內放射治療)中發揮著至關重要的作用。這種先進的設備可以將放射源精確地放置在需要治療的組織內或附近,同時最大限度地減少醫務人員的輻射暴露。施用器是近距離放射治療中用於將放射源放置在治療區域的重要儀器。這些設備有各種形狀和尺寸,並針對特定的身體部位和治療方案量身定做。術中放射治療系統是用於在手術期間向腫瘤部位輸送放射線的最先進的設備。 IORT系統可以在切除腫瘤後直接進行放射治療,同時暫時轉移和保護周圍的健康組織。種子是指用於近距離放射治療的小型放射性植入,稱為種子植入。這些種子被直接植入前列腺並持續發射輻射,但劑量會隨著時間的推移而減少,以破壞癌細胞。
應用範例乳癌盛行率的增加正在推動放射治療設備的引入。
在治療淋巴瘤、白血病和骨髓瘤等血癌時,放射線治療可用於破壞骨髓、脾臟和其他疾病擴散區域的癌細胞。在幹細胞移植之前也會進行放射線治療,以使身體為新的造血細胞做好準備。放射線治療是乳癌治療的主要手段。它用於破壞手術後乳房、胸壁和腋窩中剩餘的癌細胞。在某些情況下,它可以在手術前用於縮小腫瘤或安寧療護以緩解晚期癌症的症狀。放射線治療可用於外用和內用治療胃腸道癌症,如胃癌、結腸癌、直腸癌和胰腺癌。它通常在手術前用於縮小腫瘤,並在手術後用於靶向剩餘的癌細胞。在安寧療護中緩解疼痛、出血和阻塞也很重要。攝護腺癌的放射線治療包括體外放射治療和近距離放射治療。放射線治療可用作主要治療或手術後治療殘留癌症。影像導引放射線治療(IGRT) 和調調變放射線治療(IMRT) 等先進技術可實現更精確的放射標靶並最大限度地減少對周圍組織的損傷。對於肺癌和其他呼吸道癌症,放射線治療可以作為主要治療方法或與其他治療方法結合。它對小細胞肺癌和非小細胞肺癌的治療有效,特別是對於無法接受手術的患者。立體定位放射線治療是一種先進的放射治療形式,可為較小的肺部腫瘤提供精準治療。放射線治療可用於治療鱗狀細胞癌和基底細胞癌(一種皮膚癌)。放射線治療是一種非侵入性治療方法,當不首選手術或其他健康問題導致手術有危險時,可以考慮放射治療。放射線治療可能是一種根治性治療方法,也可能用於緩解晚期癌症的症狀。在非癌症應用中,放射治療機用於治療良性疾病,例如甲狀腺毒症和某些發炎疾病。在非癌症治療中對放射線治療的偏好是基於其標靶作用,並且在某些情況下,其能夠提供手術和藥物治療的非侵入性替代方案。
最終用戶:由於患者數量龐大,醫院優先考慮多功能、高通量系統。
放射治療設備最大的最終使用者群體是醫院。患者通常需要廣泛的放射治療解決方案來滿足他們的多樣化需求。醫院安裝了各種類型的放射治療設備,包括直線加速器、質子治療系統和近距離放射治療系統,以提供全面的癌症治療服務。專科診所通常專注於治療特定的癌症類型,因此需要根據其特定需求量身定做的專門放射治療設備。這些診所喜歡經過最佳化以治療特定癌症類型的設備,對於小型患者群體來說具有成本效益,並且可以輕鬆整合到小型臨床環境中。
區域洞察
美洲地區是放射治療設備的已開發市場,並得到了提供高度自動化設備和發達的癌症護理基礎設施的老牌公司的支持。在美國和加拿大,癌症治療的保險報銷範圍擴大,使患者能夠使用各種設備接受高品質的治療。亞太地區癌症患者盛行率較高,醫療機構不斷進行研發以開發需要新設備的改良治療方法。歐洲地區擁有一些在提供放射治療設備方面擁有多年經驗的知名公司。政府針對癌症治療採取了多項措施和宣傳計劃,增加了患者對早期手術的偏好。歐洲醫療機構和美國食品藥物管理局為放射治療設備的核准和銷售提供嚴格的指導方針。然而,近年來,一些公司已開始在這些國家獲得商業化批准,作為癌症治療的必需產品。
FPNV定位矩陣
FPNV定位矩陣對於評估放射治療設備市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對放射治療設備市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.放射治療設備市場的市場規模與預測為何?
2.在放射治療設備市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.放射治療設備市場的技術趨勢和法規結構是什麼?
4.放射治療設備市場主要廠商的市場佔有率?
5.進入放射治療設備市場的合適型態和策略手段是什麼?
[183 Pages Report] The Radiation Therapy Equipment Market size was estimated at USD 7.76 billion in 2023 and expected to reach USD 8.28 billion in 2024, at a CAGR 7.11% to reach USD 12.55 billion by 2030.
Radiation therapy equipment is a type of medical equipment used to treat cancer and other conditions with radiation. Radiation therapy has the ability to precisely target tumors while minimizing injury to nearby healthy tissue. Radiation therapy equipment is mostly of high power and has the ability to deliver different dose levels, allowing doctors to customize treatment plans for each patient. The prevalence of cancer and the increasing adoption of surgical procedures have been the major factors driving the need for advanced radiotherapy equipment. Governments have taken multiple initiatives to expand access to cancer treatment, and improved reimbursement coverage has enabled more patients to adopt the treatment. However, the stringent government regulations regarding the approval of equipment have been impeding their penetration in many economies. Market players are consistently working on enhancing the operational abilities of radiotherapy equipment with digital and automated advancements and are maintaining the utmost quality care to ensure fast product approval. Moreover, exponential private-public investments in cancer treatment R&D are expected to encourage the development of new treatment equipment.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 7.76 billion |
Estimated Year [2024] | USD 8.28 billion |
Forecast Year [2030] | USD 12.55 billion |
CAGR (%) | 7.11% |
Type: Ongoing advancements in particle therapy systems to deliver more precise radiation therapy
External beam radiotherapy (EBRT) is a non-invasive method for providing high doses of radiation to tumors from outside the body. Conventional Cobalt-60 teletherapy units are one of the earliest forms of external beam radiotherapy equipment used in the treatment of cancer. These units operate by using gamma rays emitted from a radioactive Cobalt-60 source to destroy cancerous tissues. Linear accelerators, referred to as linacs, are the modern external beam radiotherapy. Linear accelerators deliver high-energy X-rays and electrons to the region of the patient's tumor. These devices are highly versatile, permitting a considerable degree of precision and control over the radiation dose delivered, which can be modulated to conform to the three-dimensional shape of the tumor. Particle therapy systems represent a cutting-edge and sophisticated subset of external beam radiotherapy that uses particles such as protons and heavy ions instead of X-rays to treat cancer. These systems, including proton therapy and carbon ion therapy, allow for precise delivery of radiation with a distinct physical advantage known as the Bragg peak, where the maximum energy release occurs just before the particles come to a stop within the tissue. Internal beam radiotherapy involves placing radiation sources inside and adjacent to the tumor itself. This type of therapy is necessary when a high dose of radiation is required directly at the tumor site, which is often used in the treatment of prostate, cervical, and breast cancers. Afterloaders play a pivotal role in brachytherapy, a type of internal beam radiotherapy. These sophisticated devices allow for the precise placement of radioactive sources within or adjacent to the tissue requiring treatment while minimizing exposure to healthcare personnel. Applicators are vital instruments used in brachytherapy to position radioactive sources at the treatment site. These tools come in various shapes and sizes, tailored to specific body sites and treatment protocols. Intraoperative radiotherapy systems are cutting-edge devices used to provide radiation to a tumor site during surgery. IORT systems allow for direct radiation delivery after the tumor is removed, while the surrounding healthy tissue can be temporarily displaced and protected. Seeds refer to tiny radioactive implants used in a form of brachytherapy called seed implantation. These seeds are implanted directly into the prostate gland, emitting a continuous but diminishing dose of radiation over time to destroy cancer cells.
Application: Increasing prevalence of breast cancer drives the deployment of radiation therapy equipment
In the treatment of blood cancers such as lymphoma, leukemia, and myeloma, radiation therapy can be used to destroy cancerous cells in the bone marrow, spleen, and other areas where the disease has spread. It can be used before a stem cell transplant to prepare the body to receive new blood-forming cells. Radiation therapy is a mainstay in breast cancer treatment. Post-surgery, it can be used to destroy any remaining tumor cells in the breast, chest wall, and axilla. In certain cases, it can be employed prior to surgery to shrink tumors and used palliatively to relieve symptoms of advanced cancer. For gastrointestinal cancers, including cancer of the stomach, colon, rectum, and pancreas, radiation therapy can be applied externally and internally. It is often used preoperatively to reduce tumor size and postoperatively to target residual cancer cells. It can also be essential for palliative care to alleviate pain, bleeding, and blockages. Radiation therapy for prostate cancer can be delivered through external beam radiation and brachytherapy. It can serve as a primary treatment and be used after surgery to treat remaining cancer. Advanced techniques such as image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT) allow for more precise targeting, minimizing damage to surrounding tissues. For lung and other respiratory cancers, radiation therapy can be a primary treatment and combined with other modalities. It is effective in managing small-cell and non-small-cell lung cancers, particularly for patients who cannot undergo surgery. Stereotactic body radiation therapy is a developed form offering high-precision treatment for smaller lung tumors. Radiation therapy is useful in treating squamous cell carcinoma and basal cell carcinoma, a type of skin cancer. It is a non-invasive remedy option that can be considered if surgery is not preferred and if the patient has other health issues that make surgery risky. Radiation therapy can be a curative treatment or used to relieve symptoms in advanced cancers. In non-cancer applications, radiation therapy equipment is used in the treatment of benign diseases, such as thyrotoxicosis and certain inflammatory disorders. The preference for radiation therapy in non-cancer treatments is based on the targeted action and capability to provide a non-invasive treatment option that can replace surgery and pharmacological interventions in some cases.
End-User: Hospitals prioritize versatile and high-throughput systems due to their large patient base
Hospitals represent the largest end-user segment for radiation therapy equipment. They often require a broad range of radiation therapy solutions to cater to diverse patient needs. Hospitals benefit from having different types of radiation therapy equipment, such as linear accelerators, proton therapy systems, and brachytherapy systems, to provide comprehensive cancer treatment services. Specialty clinics often focus on treating specific types of cancers and, as such, require specialized radiation therapy equipment tailored to their particular needs. The preference for these clinics includes equipment that is optimized for the treatment of specific cancer types, is cost-effective for lower patient volumes, and can be easily integrated into smaller clinical settings.
Regional Insights
The Americas region observes an advanced market for radiation therapy equipment supported by the presence of established players offering highly automated equipment and developed cancer care infrastructure. The U.S. and Canada have expanded the provision of reimbursements for cancer care, which has enabled patients to access quality care with different equipment. The Asia-Pacific region observes a high prevalence of cancer cases, and medical institutes are constantly conducting R&D studies to develop improved therapies, which require new equipment. The European region has the presence of the most well-recognized players, with years of experience in offering radiotherapy equipment. Several government initiatives and awareness programs for cancer treatment have expanded the patient preference for surgeries in the early stages. The European Medical Agency and the U.S. Food and Drug Administration provide strict guidelines regarding the approval and marketing of radiotherapy equipment. However, in recent years, players have been able to achieve commercialization authorization in these countries for products that can be essential in cancer treatment.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Radiation Therapy Equipment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Radiation Therapy Equipment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Radiation Therapy Equipment Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Allengers Medical Systems Ltd, BEBIG Medical GmbH, Bionix LLC, BrainLab AG, Canon Inc., Carl Zeiss AG, Eckert and Ziegler AG, Elekta AB, GE HealthCare Technologies Inc., Hitachi, Ltd., IntraOp Medical Corp., Ion Beam Applications S.A., Klarity Medical & Equipment (GZ) Co., Ltd., LINEV Group, Mevion Medical Systems, Inc., MinXray, Inc., Mitsubishi Heavy Industries, Ltd., Nordion by Sotera Health LLC, Oraya Therapeutics Inc., PTW Freiburg GmbH, RefleXion Medical, Inc., Royal Philips, Siemens Healthineers AG, Stryker Corporation, Sumitomo Heavy Industries, Ltd., and Xstrahl Group.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Radiation Therapy Equipment Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Radiation Therapy Equipment Market?
3. What are the technology trends and regulatory frameworks in the Radiation Therapy Equipment Market?
4. What is the market share of the leading vendors in the Radiation Therapy Equipment Market?
5. Which modes and strategic moves are suitable for entering the Radiation Therapy Equipment Market?